Zura Bio Limited logo ZURA - Zura Bio Limited

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 6
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $20.00 DETAILS
HIGH: $20.00
LOW: $20.00
MEDIAN: $20.00
CONSENSUS: $20.00
UPSIDE: 473.07%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 20.7 14.7 11.0 11.9 8.7 10.5 9.2 6.0 5.5 3.6 6.9 4.0 28.2 4.9 23.2 0.4 0.1 7.5 0 0 0 0
SG&A Expenses 8.6 10.8 7.5 7.6 9.4 8.8 6.5 13.3 6.2 4.8 3.9 6.2 5.7 2.8 1.6 0.7 0.8 0.3 0.5 0.3 0.0 0.2
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (7.4) 0 0 0 0
Operating Expenses 29.3 25.5 18.4 19.5 18.1 19.3 15.7 19.3 11.8 8.4 10.8 10.2 33.9 7.7 24.8 1.1 0.9 0.4 0.5 0.3 0.0 0.2
Operating Income
Operating Income (29.3) (25.5) (18.4) (19.5) (18.1) (19.3) (15.7) (19.3) (11.8) (8.4) (10.8) (10.2) (33.9) (7.7) (24.8) (1.1) (0.9) (0.4) (0.5) (0.3) (0.0) (0.2)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 1.9 1.3 1.3 1.5 1.7 1.8 2.1 2.5 2.2 1.2 1.4 0.8 0 0.0 (0.0) 0 0 0.0 0.0 0.0 0 0.0
Profitability
EBITDA (26.4) (24.2) (17.2) (18.0) (16.0) (17.4) (13.6) (20.7) (10.3) (7.7) (8.5) (8.3) (0.1) (9.8) (25.3) (0.0) (0.9) 0.1 0.8 5.8 (0.0) 1.8
EBIT (26.4) (24.2) (17.2) (18.0) (16.0) (17.4) (13.6) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.8) (25.3) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
Income Before Tax (26.4) (24.2) (17.2) (18.0) (16.0) (17.4) (13.6) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.8) (25.5) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
Income Tax Expense (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (26.3) (24.2) (17.2) (18.0) (16.0) (17.4) (9.0) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.6) (23.9) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
Per Share Data
EPS (Basic) -0.21 -0.22 -0.49 -0.21 -0.17 -0.19 -0.14 -0.26 -0.17 -0.02 -0.18 -0.18 -0.99 -0.27 0.32 -0.06 -0.05 0.01 0.05 0.34 -0.00 0.01
EPS (Diluted) -0.21 -0.22 -0.49 -0.21 -0.17 -0.27 -0.14 -0.26 -0.17 -0.02 -0.18 -0.18 -0.99 -0.27 0.32 -0.06 -0.05 0.01 0.05 0.34 -0.00 0.01
Shares Outstanding 126.8 112.2 94.2 94.6 94.3 65.3 65.3 87.3 74.9 46.9 47.0 46.9 34.3 35.5 17.2 17.2 17.2 17.2 17.2 17.2 17.2 17.2
Metric 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Current Assets
Cash & Cash Equivalents 187.7 205.1 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 1.6 3.0 4.4 4.7 0.7 1.0 0.0
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.9 5.4 1.4 2.9 3.3 2.5 1.1 2.2 0.8 1.0 0.7 1.0 0.7 0.5 0 0.2 0 1.2 0 0 0 0
Total Current Assets 191.6 210.5 227.0 112.3 142.3 157.0 171.7 178.7 189.0 189.5 90.5 100.8 104.6 113.3 44.4 1.8 3.3 5.6 4.7 1.2 1.5 0.0
Non-Current Assets
Property, Plant & Equipment 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 139.4 139.4 0
Other Non-Current Assets 2.9 2.8 1.5 1.5 1.5 0.7 0.7 0.7 0.1 0 0 0 0 0 0 3.5 1.9 0 0 0 0 0.1
Total Non-Current Assets 3.0 2.9 1.6 1.6 1.6 0.8 0.8 0.8 0.1 0.0 0.0 0 0 0 0 3.5 1.9 0 0 139.4 139.4 0.1
Total Assets 194.6 213.4 228.6 113.9 143.9 157.8 172.5 179.5 189.1 189.5 90.5 100.8 104.6 113.3 44.4 5.3 5.2 5.6 4.7 140.6 140.9 0.2
Current Liabilities
Account Payables 0 0 2.1 1.3 3.3 1.2 1.2 0.7 1.0 1.0 1.5 2.7 1.6 7.1 2.4 2.0 1.1 0.2 0 0 0 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.8 0 0 0 0 0 0.1
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 17.0 16.3 1.1 3.3 7.2 1.4 0.7 1.7 1.4 12.6 0.4 1.2 15.0 0.6 0.9 2.8 0 0.1 0.0 0.3 0.1 0.1
Total Current Liabilities 17.0 16.3 11.7 12.4 25.5 18.7 21.1 19.5 18.2 15.1 14.7 20.3 17.0 19.9 5.0 14.8 2.2 1.5 0.0 0.3 0.1 0.2
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 2.4 1.6 1.0 1.9 2.1 1.5 12.5 12.5 12.5 12.5 10.1 11.7 0
Total Non-Current Liabilities 0 0 0 0 0 0 0 0 0 2.4 1.6 1.0 1.9 2.1 1.5 12.5 12.5 12.5 12.5 10.1 11.7 0
Total Liabilities 17.0 16.3 11.7 12.4 25.5 18.7 21.1 19.5 18.2 17.4 16.3 21.3 19.0 22.0 6.5 27.3 14.7 14.0 12.5 10.4 11.8 0.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 139.4 139.4 0.0
Retained Earnings (300.9) (275.1) (248.8) (224.5) (207.4) (189.3) (173.3) (155.9) (142.3) (121.6) (111.2) (103.5) (95.0) (86.8) (41.9) (32.1) (9.8) (8.7) (7.8) (9.2) (10.3) (0.1)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 177.7 197.1 216.9 101.5 108.2 125.9 138.2 146.8 153.0 156.5 61.0 59.3 63.2 68.9 27.9 (32.1) (9.5) (8.4) (7.8) 130.2 129.1 (0.0)
Total Liabilities & Equity 194.6 213.4 228.6 113.9 143.9 157.8 172.5 179.5 189.1 189.5 90.5 100.8 104.6 113.3 44.4 5.3 5.2 5.6 4.7 140.6 140.9 0.2
Debt Metrics
Total Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.8 0 0 0 0 0 0.1
Net Debt (187.7) (205.1) (225.6) (109.4) (139.0) (154.5) (170.6) (176.5) (188.2) (188.4) (89.8) (99.8) (103.9) (112.8) (44.0) 6.2 (3.0) (4.4) (4.7) (0.7) (1.0) 0.1
Metric 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Operating Activities
Net Income (25.8) (26.3) (24.2) (17.2) (20.0) (16.0) (17.4) (11.3) (20.7) (12.7) (7.7) (8.5) (8.3) (34.0) (9.8) 0.5 2.3 0.1 0.8 5.8
Depreciation & Amortization 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 33.9 0 1.1 0 0 0 0
Stock-Based Compensation 5.3 4.5 5.0 2.6 0 3.7 3.6 2.8 8.6 2.9 2.4 2.4 2.6 2.3 2.4 0 0 0 0 0
Change in Working Capital 0 3.6 0.3 (2.7) 0.2 (3.8) 2.7 (0.0) 2.5 0.0 (0.2) 3.0 2.8 (1.0) 0.2 0.3 0.6 0.2 0.3 (0.5)
Other Non-Cash Items 0.8 0.0 0.0 (5.0) 4.4 0.0 0.0 (2.3) 3.9 3.1 0.6 (1.0) 0.3 (6.4) 3.9 (2.1) (3.3) (0.6) (1.3) (6.1)
Operating Cash Flow (19.5) (20.9) (18.9) (22.3) (15.4) (16.0) (11.1) (10.8) (5.7) (6.6) (5.0) (4.1) (2.6) (5.2) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)
Investing Activities
Capital Expenditure (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (5.0) 0 (2.2) (5.8) 0 (0.0) (0.0) 0 0.0 (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (139.4)
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 (5) 0 0 (5) 0 0 0 0 0 0 0 0 0
Investing Cash Flow (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (5.0) 0 (2.2) (5.8) 0 0 0 0 0 (139.4)
Financing Activities
Net Debt Issuance 0 0 0 0 (0.1) 0 0.1 0 0 0 0 0 0 0 (10) 0.1 0.2 0 0 (0.1)
Stock Repurchased 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 2.1 0 0 (7.3) 0 0 0 59.9 (0.1) 50.0 0 0 0 15.9 (1.0) 0 0 0 0 0.5
Financing Cash Flow 2.1 0.5 135.1 (7.3) 0.0 (0.0) 5.2 (0.9) 5.4 105.3 0 0 (4.1) 79.8 45.7 0.1 0.2 0 0 141.2
Cash Position
Net Change in Cash (17.5) (20.5) 116.2 (29.6) (15.5) (16.1) (5.9) (11.7) (0.2) 98.6 (10.0) (4.1) (8.9) 68.8 42.4 (0.1) (0.3) (0.2) (0.3) 1.0
Cash at Beginning 205.1 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 1.6 0.2 0.5 0.7 1.0 0.0
Cash at End 187.7 205.1 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 0.1 0.2 0.5 0.7 1.0
Free Cash Flow (19.5) (20.9) (18.9) (22.3) (15.5) (16.0) (11.1) (10.9) (5.7) (6.6) (10.0) (4.1) (4.8) (10.9) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (29.3) (25.5) (18.4) (19.5) (18.1) (19.3) (15.7) (19.3) (11.8) (8.4) (10.8) (10.2) (33.9) (7.7) (24.8) (1.1) (0.9) (0.4) (0.5) (0.3) (0.0) (0.2)
Net Income (26.3) (24.2) (17.2) (18.0) (16.0) (17.4) (9.0) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.6) (23.9) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
EPS (Diluted) -0.21 -0.22 -0.49 -0.21 -0.17 -0.27 -0.14 -0.26 -0.17 -0.02 -0.18 -0.18 -0.99 -0.27 0.32 -0.06 -0.05 0.01 0.05 0.34 -0.00 0.01
Balance Sheet
Cash & Equivalents 187.7 205.1 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 1.6 3.0 4.4 4.7 0.7 1.0 0.0
Total Assets 194.6 213.4 228.6 113.9 143.9 157.8 172.5 179.5 189.1 189.5 90.5 100.8 104.6 113.3 44.4 5.3 5.2 5.6 4.7 140.6 140.9 0.2
Total Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.8 0 0 0 0 0 0.1
Stockholders' Equity 177.7 197.1 216.9 101.5 108.2 125.9 138.2 146.8 153.0 156.5 61.0 59.3 63.2 68.9 27.9 (32.1) (9.5) (8.4) (7.8) 130.2 129.1 (0.0)
Cash Flow
Operating Cash Flow (19.5) (20.9) (18.9) (22.3) (15.4) (16.0) (11.1) (10.8) (5.7) (6.6) (5.0) (4.1) (2.6) (5.2) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)
Capital Expenditure (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (5.0) 0 (2.2) (5.8) 0 (0.0) (0.0) 0 0.0 (0.0)
Free Cash Flow (19.5) (20.9) (18.9) (22.3) (15.5) (16.0) (11.1) (10.9) (5.7) (6.6) (10.0) (4.1) (4.8) (10.9) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)